Asia Pacific Cryoablation Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Tissue Contact Probe Ablators, Tissue Spray Probe Ablators, and Epidermal & Subcutaneous Cryoablation Systems), By Application (Lung Cancer, Liver Cancer, Cardiac Arrhythmia, and Others), By End-Use (Hospital, Outpatient Facilities, and Research & Manufacturing), and Asia Pacific Cryoablation Devices Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Cryoablation Devices Market Insights Forecasts to 2035

• The Asia Pacific Cryoablation Devices Market Size was Estimated at USD 117.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 15.35% from 2025 to 2035
• The Asia Pacific Cryoablation Devices Market Size is Expected to Reach USD 566.6 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the Asia Pacific Cryoablation Devices Market is anticipated to reach USD 566.6 million by 2035, growing at a CAGR of 15.35% from 2025 to 2035. The growing prevalence of cancer and cardiac diseases, along with the adoption of minimally invasive procedures, is driving the cryoablation devices market in the Asia Pacific region.

Market Overview

The Asia Pacific cryoablation devices market refers to the industry that emphasizes the development, manufacturing, and sale of medical devices used in cryoablation procedures, which are techniques that destroy unwanted tissue by freezing it. Cryoablation is a treatment used by healthcare providers for treating small tumors or when surgery isn’t an option. The device works by freezing cancer cells and eliminating tumors. The procedure includes shrinking tumors that are pressing on nerves or nearby organs. Patients and surgeons changing inclination towards non-invasive or minimally invasive treatment procedures owing to several factors, including patient comfort, speedy recovery, and minimized turnaround time, is driving the demand for cryoablation devices. Region’s healthcare infrastructure and emphasis on developing advanced cryoablation devices, along with an increasing patient population in developing countries like India, Thailand, and China, are emerging trends in the cryoablation devices market. An increasing adoption of cryotherapy as a pain management method, along with an increasing healthcare expenditure and rapidly expanding medical tourism, is providing a significant market growth opportunity.

Report Coverage

This research report categorizes the market for the Asia Pacific cryoablation devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific cryoablation devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific cryoablation devices market.

Driving Factors

An increasing prevalence of cancer and cardiac diseases is anticipated to drive the market demand. It was estimated that among the 18.6 million CVD deaths worldwide in 2019, 58% occurred in Asia. The cryoablation method is used to ease pain and other symptoms caused by cancer that has spread to the bone, to other organs, or lymph nodes. An increasing incorporation of cryoablation technology into clinical protocols by hospitals, outpatient facilities, and research institutions is propelling the market growth. The adoption of minimally invasive procedures and technological advancements in cryoablation equipment is driving the market growth.

Restraining Factors

An increased cost of cryoablation procedures is challenging the market. Further, the lack of awareness and expertise required for handling cryoablation devices is hampering the market growth.

Market Segmentation

The Asia Pacific cryoablation devices market share is classified into product, application, and end-use.

• The tissue contact probe ablators segment dominated the market with a significant share in 2024 and is expected to grow at the fastest CAGR during the forecast period.

The Asia Pacific cryoablation devices market is segmented by product into tissue contact probe ablators, tissue spray probe ablators, and epidermal & subcutaneous cryoablation systems. Among these, the tissue contact probe ablators segment dominated the market with a significant share in 2024 and is expected to grow at the fastest CAGR during the forecast period. Tissue contact probe ablators, used in radiofrequency and microwave ablation procedures, are vital tools in modern surgical oncology and cardiology. Development of advanced healthcare infrastructure, with increasing emphasis on developing advanced cryoablation devices, is contributing to driving the market in the tissue contact probe ablators segment.

• The cardiac arrhythmia segment dominated the cryoablation devices market in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific cryoablation devices market is segmented by application into lung cancer, liver cancer, cardiac arrhythmia, and others. Among these, the cardiac arrhythmia segment dominated the cryoablation devices market in 2024 and is expected to grow at a significant CAGR during the forecast period. Cryoablation, like cryoenergy, is considered safe in catheter ablation of arrhythmia, appropriately controls freezing temperature, rendering myocardial lesions reversible. The growing cases of cardiovascular disorders are anticipated to drive the market, as the disorder has an increased risk of developing heart damage.

•  The hospital segment dominated the market with the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific cryoablation devices market is segmented by end-use into hospital, outpatient facilities, and research & manufacturing. Among these, the hospital segment dominated the market with the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. An increasing number of cardiac surgeries performed in hospitals is driving the cryoablation devices market. Further, the growing cases of cancer are also contributing to driving the demand for cryoablation.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific cryoablation devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boston Scientific Corporation
• Micro Port Scientific Corporation
• Medtronic
• COOPERSURGICAL, INC.
• ATRICURE, INC.
• Ice Cure Medical
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Cryoablation Devices Market based on the below-mentioned segments:

Asia Pacific Cryoablation Devices Market, By Product

• Tissue Contact Probe Ablators
• Tissue Spray Probe Ablators
• Epidermal & Subcutaneous Cryoablation Systems

Asia Pacific Cryoablation Devices Market, By Application

• Lung Cancer
• Liver Cancer
• Cardiac Arrhythmia
• Others

Asia Pacific Cryoablation Devices Market, By End-Use

• Hospital
• Outpatient Facilities
• Research & Manufacturing